Is the price fair?
What MDT's price assumes
Medtronic trades at 24.6× earnings against 33.4× for the median Medical Devices name, cheaper than its own group.
24.6
Trailing P/E · Medical Devices median 33.4 · cheaper than the typical name in its group
- Price / sales
- 2.93
Price / sales · as of 2026-Q2
- Free cash flow yield
- 5.3%
Free cash flow yield · Medical Devices median 4.0%
- Growth the price implies
- +4.8%
Growth the price implies · The price pays for +4.8% free cash flow growth a year for a decade; the business has delivered +5.8% a year over the last three.
Details›
- Price / book2026-Q2
- 2.16
- Healthcare median P/E362 names
- 31.5
- Medical Devices median P/E39 names
- 33.4
- Free cash flow, trailing twelve months
- $5.43B
- Market capitalisation
- $101.9B
- 3-year revenue growth
- +5.2%
- 3-year free cash flow growth
- +5.8%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $92.39 |
| Its own P/E history, median | $96.71 |
| Its own P/E history, upper quartile | $105.20 |
| 52-week range | $73.75 – $103.73 |
| Today | $92.01 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
Ranks #11 of 35 by Smart Score